[Specific immunostimulation in the therapy of recurrent herpes simplex type I or II].

The results of a study on the efficacy and tolerability of an immunotherapy with viral inactivated products in comparison with the usual antivirals on patients affected with herpes simplex I or II, are presented. The very good results obtained with the vaccine concerning frequency, intensity and duration of relapses (67% of cases with complete absence of relapse) are in good relation with an active stimulation due to the drug on the cell-mediated component of the immunity response. The examined antivirals allow to obtain a significant decrease of the intensity and duration of the relapses without interfering in any way with the immunity system.